Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean Study

NCT05053152 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

194

Enrollment

OTHER

Sponsor class

Conditions

Oligometastatic Prostate Carcinoma
Prostate Adenocarcinoma
Prostate Ductal Adenocarcinoma
Prostate Intraductal Carcinoma
Stage IVB Prostate Cancer AJCC v8

Interventions

PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Scan
PROCEDURE: Computed Tomography
OTHER: Fluciclovine F18
PROCEDURE: Magnetic Resonance Imaging
DRUG: Placebo Administration
PROCEDURE: Positron Emission Tomography
PROCEDURE: PSMA PET Scan
DRUG: Relugolix
RADIATION: Stereotactic Body Radiation Therapy

Sponsor

NRG Oncology

Collaborators

[object Object]